Dr Helen Fletcher talks about progress in the development of a vaccine against tuberculosis.
Tuberculosis kills two million people annually, with the majority of infection occurring in developing countries. Dr Helen Fletcher works on multi-partner projects to discover biomarkers of protection from TB disease, develop clinical trials capacity in Africa, and develop new vaccines for TB. Dr Fletcher has also developed her own research programme on transcriptional profiling of immune responses following both TB and malaria vaccination.
